terbutaline has been researched along with Cancer of Liver in 2 studies
Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thomas, P | 1 |
| Hayashi, H | 1 |
| Zimmer, R | 1 |
| Forse, RA | 1 |
| Shwed, JA | 1 |
| Walle, UK | 1 |
| Walle, T | 1 |
2 other studies available for terbutaline and Cancer of Liver
| Article | Year |
|---|---|
Regulation of cytokine production in carcinoembryonic antigen stimulated Kupffer cells by beta-2 adrenergic receptors: implications for hepatic metastasis.
Topics: Adrenergic beta-Agonists; Animals; Carcinoembryonic Antigen; Cytokines; Gene Expression Profiling; I | 2004 |
Hep G2 cell line as a human model for sulphate conjugation of drugs.
Topics: Arylsulfotransferase; Carcinoma, Hepatocellular; Dopamine; Humans; Liver; Liver Neoplasms; Nitrophen | 1992 |